# Establishing Reference Intervals for Fat-Soluble Vitamins in Healthy Chinese Adults: Study Protocol for a Cross-Sectional, Multicenter Study

**Authors:** Zhong Liu, Chenbing Liu, Nan Li, Chao Shen, Lihong Qiu, Di Sheng

PMC · DOI: 10.2196/80425 · JMIR Research Protocols · 2026-02-17

## TL;DR

This study aims to create accurate reference ranges for fat-soluble vitamins in healthy Chinese adults to improve clinical assessments and disease prevention.

## Contribution

The study will generate the first large-scale, population-specific reference intervals for all four fat-soluble vitamins in healthy Chinese adults.

## Key findings

- The study will recruit 100,000 adults across 20 hospitals in China to establish reference intervals.
- As of October 2025, 1,690 participants have met inclusion criteria out of 13,545 enrolled.
- Findings are expected to be published in 2027 and will support better clinical nutrition assessment in China.

## Abstract

Fat-soluble vitamins (FSVs)—vitamins A, D, E, and K—are essential micronutrients involved in key physiological processes. Both deficiency and excess can influence nutritional assessment and disease risk. In China, clinical evaluation of FSVs often relies on reference intervals (RIs) derived from Western populations, and no large-scale study has comprehensively evaluated all 4 FSVs in healthy Chinese adults.

The aim of this study is to establish population-specific RIs for vitamins A, D, E, and K in healthy Chinese adults, thereby supporting more accurate clinical assessment of vitamin status and the prevention of related diseases.

This ongoing multicenter cross-sectional study aims to recruit 100,000 adults (≥18 y) from 20 hospitals across China. Participants undergo a standardized questionnaire, physical examination, and blood sample collection. FSV concentrations are quantified using liquid chromatography-tandem mass spectrometry. Group differences are assessed using the chi-square test or Fisher exact test. Nested ANOVA evaluates variation across subgroups. RIs will be established using parametric or nonparametric percentile methods following rigorous outlier removal to accurately determine the 2.5th and 97.5th percentile limits.

As of October 2025, 13,545 adults have been enrolled, and 1690 participants have met the inclusion criteria. Recruitment began on 1 July 2024 and is expected to conclude by 30 June 2026.

This study will generate the first large-scale, population-specific RIs for FSVs in healthy Chinese adults. The findings are expected to be published in 2027 and will provide an important evidence base for clinical nutrition assessment and disease prevention in China.

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}
- **Diseases:** infection (MESH:D007239), blood coagulation (MESH:D001778), cardiovascular and cerebrovascular diseases (MESH:D002318), acute and chronic infections (MESH:D054198), toxicities (MESH:D064420), osteoporosis (MESH:D010024), Vitamin E deficiency (MESH:D014811), anemia (MESH:D000740), CLSI (MESH:D007757), malnutrition (MESH:D044342), CS (MESH:D006223), cancers (MESH:D009369), diabetes (MESH:D003920), liver and kidney disease (MESH:D008107), nervous system abnormalities (MESH:D009421), hyperlipidemia (MESH:D006949), impaired vision (MESH:D014786), night blindness (MESH:D009755), bone fracture (MESH:D050723), stunted growth (MESH:D006130), autoimmune diseases (MESH:D001327), FSVs (MESH:C565532), Deficiency in vitamin D (MESH:D014808)
- **Chemicals:** Vitamin K (MESH:D014812), tocopherols (MESH:D024505), A, D, E, and K (-), 25-hydroxyvitamin D3 (MESH:D002112), bile acid (MESH:D001647), Alcohol (MESH:D000438), glucose (MESH:D005947), calcium (MESH:D002118), lipid (MESH:D008055), Vitamin E (MESH:D014810), uric acid (MESH:D014527), 25-hydroxyvitamin D2 (MESH:D015652), triglyceride (MESH:D014280), Fat (MESH:D005223), Vitamin D (MESH:D014807), cholesterol (MESH:D002784), Vitamin A (MESH:D014801)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12912661/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12912661/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12912661/full.md

---
Source: https://tomesphere.com/paper/PMC12912661